Gregory Waller
Fortune : - $ au 31/05/2026
Fortune : - $ au 31/05/2026
Gregory D.
Waller is an Independent Non-Executive Director at Nuwellis, Inc. since 2011.
Mr. Waller is an Independent Director at Arcadia Biosciences, Inc. since 2017.
Mr. Waller is a Director at Artemis Dna, Inc. Former roles include Director at CardioGenesis Corp.
from 2007 to 2011, Director at BIOLASE, Inc. from 2009 to 2010, Director at Clarient, Inc. from 2006 to 2010, Independent Director at Endologix LLC from 2003 to 2020, Director at VivoMetrics, Inc., Director at SenoRx, Inc. from 2006 to 2010, Director at Alsius Corp.
from 2006 to 2010, Director at ALUS Liquidation Corp.
from 2007 to 2009, Chief Financial Officer, Treasurer & VP at Sybron Dental Specialties, Inc. from 1993 to 2005, Treasurer & Vice President-European Operations at Kerr Corp.
in 1993, Treasurer & Vice President at Metrex Research LLC from 1993 to 2005, Vice President & Controller at Ormco Corp.
in 1989, Chief Financial Officer at Ulthera, Inc. from 2011 to 2015, and Chief Financial Officer, Treasurer & VP at Universal Building Products, Inc. from 2006 to 2011.
Education includes undergraduate and MBA degrees from California State University-Fullerton.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NUWELLIS, INC. -.--% | 28/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| NUWELLIS, INC. | Directeur/Membre du Conseil | 03/08/2011 |
| ARCADIA BIOSCIENCES, INC. | Directeur/Membre du Conseil | 13/06/2017 |
Artemis Dna, Inc.
Artemis Dna, Inc. Artemis DNA is a full-service clinical diagnostic laboratory that specializes in precision medicine. The company is certified by the Clinical Laboratory Improvement Amendments (Clia) and accredited by the College of American Pathologists (CAP). The company offers a range of cutting-edge technologies and analytics to improve health through early detection, diagnosis, and management of diseases. The company's oncology portfolio includes a Cancer Risk Profile Panel, Trucheck Pragma Cancer Early Detection Panel, Cancertrack Cancer Monitor and Manage Recurrence Panel, and Cancer Tumor Profiling Panel, which use next-generation sequencing (NGS) and liquid biopsy tests to assess a person's increased risk of developing the disease based on their genetic makeup. The company is based in Irvine, CA. The company was founded in 2019 by Emylee Thai. Emylee Thai has been the CEO since 2019. | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| ENDOLOGIX, INC. | Directeur/Membre du Conseil | 01/10/2020 |
Ulthera, Inc.
Ulthera, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Directeur Financier/CFO | 01/10/2015 |
Universal Building Products, Inc.
Universal Building Products, Inc. Construction MaterialsNon-Energy Minerals Manufactures concrete accessories | Directeur Financier/CFO | 01/04/2011 |
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Designs, develops and distributes surgical and fiber optic lasers | Directeur/Membre du Conseil | - |
Clarient, Inc.
Clarient, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic testing services | Directeur/Membre du Conseil | 22/12/2010 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 18 |
|---|---|
CardioGenesis Corp.
CardioGenesis Corp. Medical SpecialtiesHealth Technology Designs, develops and distributes surgical and fiber optic lasers | Health Technology |
BIOLASE, Inc.
BIOLASE, Inc. Medical SpecialtiesHealth Technology Develops, manufactures, markets and sells laser systems for dental practitioners & their patients | Health Technology |
Clarient, Inc.
Clarient, Inc. Medical/Nursing ServicesHealth Services Provides cancer diagnostic testing services | Health Services |
Endologix LLC
Endologix LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for the interventional treatment of vascular disease | Health Technology |
Sybron Dental Specialties, Inc.
Sybron Dental Specialties, Inc. Medical SpecialtiesHealth Technology Manufactures and markets dental and medical products | Health Technology |
Kerr Corp.
Kerr Corp. Medical SpecialtiesHealth Technology Develops, manufactures, markets, and distributes dental products | Health Technology |
Metrex Research LLC
Metrex Research LLC Miscellaneous ManufacturingProducer Manufacturing Manufactures, designs, and markets laboratory and dental supply products | Producer Manufacturing |
Ormco Corp.
Ormco Corp. Medical SpecialtiesHealth Technology Manufactures medical suupplies brackets, bands, buccal tubes, wires and improve clinician's opportunity | Health Technology |
Nuwellis, Inc.
Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
VivoMetrics, Inc.
VivoMetrics, Inc. Medical SpecialtiesHealth Technology Provides non-invasive ambulatory monitoring systems | Health Technology |
Ulthera, Inc.
Ulthera, Inc. Medical SpecialtiesHealth Technology Develops and markets medical devices | Health Technology |
Universal Building Products, Inc.
Universal Building Products, Inc. Construction MaterialsNon-Energy Minerals Manufactures concrete accessories | Non-Energy Minerals |
California State University-Fullerton
California State University-Fullerton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SenoRx, Inc.
SenoRx, Inc. Medical SpecialtiesHealth Technology Develops and manufactures invasive devices for the diagnosis & treatment of breast cancer | Health Technology |
Arcadia Biosciences, Inc.
Arcadia Biosciences, Inc. Chemicals: AgriculturalProcess Industries Develops agriculture based technologies | Process Industries |
Alsius Corp. /Old/
Alsius Corp. /Old/ Medical DistributorsDistribution Services Provides health care products | Distribution Services |
ALUS Liquidation Corp.
ALUS Liquidation Corp. Medical SpecialtiesHealth Technology Develops, manufactures and sells medical products | Health Technology |
Artemis Dna, Inc.
Artemis Dna, Inc. Artemis DNA is a full-service clinical diagnostic laboratory that specializes in precision medicine. The company is certified by the Clinical Laboratory Improvement Amendments (Clia) and accredited by the College of American Pathologists (CAP). The company offers a range of cutting-edge technologies and analytics to improve health through early detection, diagnosis, and management of diseases. The company's oncology portfolio includes a Cancer Risk Profile Panel, Trucheck Pragma Cancer Early Detection Panel, Cancertrack Cancer Monitor and Manage Recurrence Panel, and Cancer Tumor Profiling Panel, which use next-generation sequencing (NGS) and liquid biopsy tests to assess a person's increased risk of developing the disease based on their genetic makeup. The company is based in Irvine, CA. The company was founded in 2019 by Emylee Thai. Emylee Thai has been the CEO since 2019. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national